TNSN08348A1 - Antibiotic compositions of modified release and process of production thereof - Google Patents
Antibiotic compositions of modified release and process of production thereofInfo
- Publication number
- TNSN08348A1 TNSN08348A1 TNP2008000348A TNSN08348A TNSN08348A1 TN SN08348 A1 TNSN08348 A1 TN SN08348A1 TN P2008000348 A TNP2008000348 A TN P2008000348A TN SN08348 A TNSN08348 A TN SN08348A TN SN08348 A1 TNSN08348 A1 TN SN08348A1
- Authority
- TN
- Tunisia
- Prior art keywords
- antibiotic
- dosage form
- release
- tested
- pharmaceutically acceptable
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 abstract 1
- 229960003022 amoxicillin Drugs 0.000 abstract 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000002132 β-lactam antibiotic Substances 0.000 abstract 1
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN824DE2006 | 2006-03-24 | ||
| PCT/IN2007/000086 WO2007110875A1 (fr) | 2006-03-24 | 2007-03-07 | Compositions antibiotiques a liberation modifiee et leur procede de production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN08348A1 true TNSN08348A1 (en) | 2009-12-29 |
Family
ID=38540834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2008000348A TNSN08348A1 (en) | 2006-03-24 | 2008-09-09 | Antibiotic compositions of modified release and process of production thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20090111788A1 (fr) |
| EP (1) | EP2001465A1 (fr) |
| JP (1) | JP2009530367A (fr) |
| KR (1) | KR20090006123A (fr) |
| CN (1) | CN101410109A (fr) |
| AU (1) | AU2007230546A1 (fr) |
| BR (1) | BRPI0709179A2 (fr) |
| CA (1) | CA2644911A1 (fr) |
| CR (1) | CR10388A (fr) |
| EA (1) | EA200870368A1 (fr) |
| MA (1) | MA30335B1 (fr) |
| MX (1) | MX2008012260A (fr) |
| RS (1) | RS20080430A (fr) |
| TN (1) | TNSN08348A1 (fr) |
| WO (1) | WO2007110875A1 (fr) |
| ZA (1) | ZA200807943B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008317315A1 (en) * | 2007-10-26 | 2009-04-30 | Rexahn Pharmaceuticals, Inc. | Pharmaceutical formulation of clavulanic acid |
| US20090148532A1 (en) * | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
| US20100136110A1 (en) * | 2008-09-30 | 2010-06-03 | Astellas Pharma Inc. | Granular pharmaceutical composition for oral administration |
| AU2010242948A1 (en) * | 2009-04-29 | 2011-11-24 | Rexahn Pharmaceuticals, Inc. | Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders |
| US20130131033A1 (en) * | 2010-01-13 | 2013-05-23 | Toyochem Laboratories | Pharmaceutical composition for treatment of respiratory tract infections |
| WO2011152808A1 (fr) * | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique |
| CN102861015B (zh) * | 2011-07-05 | 2015-07-08 | 北京乐维生物技术有限公司 | 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺 |
| US20150238425A1 (en) | 2012-08-28 | 2015-08-27 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Mini-tablets |
| US9254261B2 (en) * | 2014-03-03 | 2016-02-09 | Sandoz Ag | Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid |
| CA2944900C (fr) | 2014-04-04 | 2023-02-28 | Pharmaquest International Center, LLC | Comprimes monolithiques a liberation modifiee se desintegrant, contenant des granules a liberation prolongee quadri-couches |
| US10335374B2 (en) * | 2014-12-04 | 2019-07-02 | University System of Georgia, Valdosta State University | Tablet composition for anti-tuberculosis antibiotics |
| WO2016134121A1 (fr) * | 2015-02-20 | 2016-08-25 | Cytec Industries Inc. | Compositions de sulfosuccinate de dialkyle, procédé de fabrication, et méthode d'utilisation |
| JP7370125B2 (ja) * | 2018-11-09 | 2023-10-27 | 日本化薬株式会社 | エルロチニブを有効成分とする医薬錠剤 |
| JP7370124B2 (ja) * | 2018-11-09 | 2023-10-27 | 日本化薬株式会社 | エルロチニブを有効成分とする医薬錠剤 |
| CN113116860B (zh) * | 2021-04-22 | 2022-11-25 | 海南通用三洋药业有限公司 | 一种阿莫西林胶囊及其制备方法 |
| CN113398069A (zh) * | 2021-07-10 | 2021-09-17 | 四川成康动物药业有限公司 | 兽用阿莫西林与磺胺嘧啶钠混悬注射液及制备方法和装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9201930D0 (sv) * | 1992-06-24 | 1992-06-24 | Astra Ab | Gastric antibacterial treatment |
| EP1330236A2 (fr) * | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Nouvelle formulation |
| US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
-
2007
- 2007-03-07 WO PCT/IN2007/000086 patent/WO2007110875A1/fr not_active Ceased
- 2007-03-07 CA CA002644911A patent/CA2644911A1/fr not_active Abandoned
- 2007-03-07 JP JP2009501021A patent/JP2009530367A/ja not_active Abandoned
- 2007-03-07 AU AU2007230546A patent/AU2007230546A1/en not_active Abandoned
- 2007-03-07 EP EP07736547A patent/EP2001465A1/fr not_active Withdrawn
- 2007-03-07 EA EA200870368A patent/EA200870368A1/ru unknown
- 2007-03-07 MX MX2008012260A patent/MX2008012260A/es not_active Application Discontinuation
- 2007-03-07 US US12/294,353 patent/US20090111788A1/en not_active Abandoned
- 2007-03-07 KR KR1020087026154A patent/KR20090006123A/ko not_active Ceased
- 2007-03-07 RS RSP-2008/0430A patent/RS20080430A/sr unknown
- 2007-03-07 ZA ZA200807943A patent/ZA200807943B/xx unknown
- 2007-03-07 CN CNA2007800105961A patent/CN101410109A/zh active Pending
- 2007-03-07 BR BRPI0709179-6A patent/BRPI0709179A2/pt not_active IP Right Cessation
-
2008
- 2008-09-09 TN TNP2008000348A patent/TNSN08348A1/en unknown
- 2008-10-15 MA MA31291A patent/MA30335B1/fr unknown
- 2008-10-21 CR CR10388A patent/CR10388A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA30335B1 (fr) | 2009-04-01 |
| KR20090006123A (ko) | 2009-01-14 |
| CN101410109A (zh) | 2009-04-15 |
| CA2644911A1 (fr) | 2007-10-04 |
| CR10388A (es) | 2009-01-19 |
| AU2007230546A1 (en) | 2007-10-04 |
| JP2009530367A (ja) | 2009-08-27 |
| ZA200807943B (en) | 2009-11-25 |
| MX2008012260A (es) | 2008-10-07 |
| BRPI0709179A2 (pt) | 2011-06-28 |
| EP2001465A1 (fr) | 2008-12-17 |
| US20090111788A1 (en) | 2009-04-30 |
| RS20080430A (sr) | 2009-05-06 |
| WO2007110875A1 (fr) | 2007-10-04 |
| EA200870368A1 (ru) | 2009-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN08348A1 (en) | Antibiotic compositions of modified release and process of production thereof | |
| EA201071035A1 (ru) | Фармацевтические композиции модифицированного высвобождения, содержащие микофенолат, и способ их получения | |
| EP2391351B1 (fr) | Compositions pharmaceutiques comprenant des dérivés de 2-oxo-1-pyrrolidine | |
| WO2003072025A3 (fr) | Formulations a liberation modifiee d'au moins une forme de tramadol | |
| TNSN08018A1 (en) | Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor | |
| WO2007145991A3 (fr) | Compositions anti-inflammatoires et analgésiques et procédés associés | |
| MY142204A (en) | Pramipexole once-daily dosage form | |
| WO2011160136A3 (fr) | Formes pharmaceutiques orales contenant de la progestérone et procédés associés | |
| ITBO20110012A1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| WO2008104994A3 (fr) | Dérivés d'acétamide 2,2,2-tri-substitué en tant qu'activateurs de la glucokinase, leur procédé de préparation et leur application pharmaceutique | |
| TW200503775A (en) | Pharmaceutical composition and method for treating | |
| WO2001087284A3 (fr) | Composition antagoniste de l'aldosterone destinee a etre liberee durant l'acrophase de l'aldosterone | |
| EA201171109A1 (ru) | Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия | |
| WO2013022783A3 (fr) | Formes de posologie orale contenant de la progestérone et procédés associés | |
| WO2005069933A3 (fr) | Procedes permettant de traiter une maladie de type inflammatoire | |
| MY157790A (en) | Trazodone composition for once a day administration | |
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| TNSN07013A1 (en) | Anti-histaminic composition | |
| TW200603816A (en) | Risedronate compositions and their methods of use | |
| WO2010044097A3 (fr) | Nouvelle forme pharmaceutique de palipéridone et procédé de préparation de celle-ci | |
| MX2021008208A (es) | Tesofensina para la reduccion del peso corporal para pacientes con sindrome de prader-willi. | |
| UA106361C2 (ru) | Фармацевтическая композиция для лечения эссенциальной тромбоцитемии | |
| WO2006053089A3 (fr) | Methodes et formulations permettant de preparer des compositions pharmaceutiques contenant du bupropion | |
| WO2006039263A3 (fr) | Nouveaux derives 9a-azalidiques bicycliques | |
| WO2008039894A3 (fr) | Compositions pharmaceutiques d'atorvastatine |